While entirely speculative, our finding of increased intratumoral Zn content in HPV-positive OPSCC cases could provide justification for the intrinsic chemoradiosensitivity of this patient population and offer insight into ways to improve the clinical outcome of patients with HPV-negative HNSCC, who frequently harbor mutant p53. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.